John Sammut, a Clinician Scientist at The Institute of Cancer Research, London, and Honorary Consultant in Medical Oncology at The Royal Marsden NHS Foundation Trust, has been awarded the Graham Bull ...

It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...

As runners from across the globe prepare to hit London’s streets for the capital’s annual flagship running event, we hear from some of those participating in the London Marathon to raise money for our ...

Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours. Their cutting-edge technique uses artificial ...

Scientists have uncovered a promising treatment strategy for an aggressive type of leukaemia – through targeting the enzymes ...

Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the ...

Socius and Aviva staff are fundraising for the ICR after the companies joined the partnership at The London Cancer Hub in ...

The Institute of Cancer Research, London, is honoured to be a beneficiary of a motorbike ride in tribute to Dave Myers of the ...

The Breast Cancer Now Toby Robins Research Centre receives all of its funding from its parent charity Breast Cancer Now, and was opened in 1999 by Breast Cancer Now's Patron, HRH The Prince of Wales.

Our scientists are developing new ways of diagnosing and treating diverse types of blood cancers, including myeloma, which develops in the bone marrow and accounts for 15 per cent of blood cancers.

Image: Pritpal and her husband Rajinder. Credit: 'Ageing Better' I was a fit and healthy woman until I was diagnosed with myeloma in 2023. I’m 73, and three years ago I learnt how to hula hoop! My ...

Our scientists are developing new ways of diagnosing and treating diverse types of blood cancers, including myeloma, which develops in the bone marrow and accounts for 15 per cent of blood cancers.